11 December 2019 : Clinical Research
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma
Wen-Hao Xu12BCDEF*, Shen-Nan Shi23BCDEF, Jun Wang12BCDEF, Yue Xu4BDF, Xi Tian12BCF, Fang-Ning Wan12BCF, Da-Long Cao12BCF, Yuan-Yuan Qu12AEG, Hai-Liang Zhang12AEG, Ding-Wei Ye12AEGDOI: 10.12659/MSM.917754
Med Sci Monit 2019; 25:9458-9470